Quick Answer
PDS Biotechnology Corp reported Research And Development Expense of $19.03 million for the year ending 2025.
- PDS Biotechnology Corp showed a decrease of -15.7% in Research And Development Expense from 2024 to 2025.
- This data is from PDS Biotechnology Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), PDS Biotechnology Corp's Research And Development Expense has grown by 324.3%.
- Historical annual values: Fiscal year 2025: $19.03 million | Fiscal year 2024: $22.57 million | Fiscal year 2023: $27.76 million | Fiscal year 2022: $29.43 million | Fiscal year 2021: $11.25 million | Fiscal year 2020: $7.92 million | Fiscal year 2019: $6.10 million | Fiscal year 2018: $830.7 thousand | Fiscal year 2017: $34.31 million | Fiscal year 2016: $24.83 million | Fiscal year 2015: $17.84 million | Fiscal year 2014: $8.47 million | Fiscal year 2013: $4.48 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: